全部分类
  • VX-765
    VX-765的可视化放大

    VX-765

    A prodrug form of VRT-043198

    此产品仅用于科学研究,我们不为任何个人用途提供产品和服务

    VX-765的二维码
    • 库存: 现货
    可选规格
    • 包装
      价格
      促销价
      数量
    • 5mg
      ¥587.00
      470.00
      - +
    • 10mg
      ¥925.00
      740.00
      - +
    • 50mg
      ¥2137.00
      1710.00
      - +
    • 100mg
      ¥3837.00
      3070.00
      - +
    已选 0 0
    金额: ¥0.00
    首页 收藏
    • 货号: ajci9692
    • CAS: 273404-37-8
    • 别名: N-(4-氨基-3-氯苯甲酰基)-3-甲基-L-缬氨酰-N-[(2R,3S)-2-乙氧基四氢-5-氧代-3-呋喃基]-L-脯氨酰胺,VX-765
    • 分子式: C24H33ClN4O6
    • 分子量: 508.99
    • 纯度: >98%
    • 溶解度: ≥ 313 mg/mL in DMSO, ≥ 50.5 mg/mL in EtOH with ultrasonic
    • 储存: Desiccate at -20°C
    • 库存: 现货

    Background

    VX-765 is a newly developed, selective, small molecule caspase-1 inhibitor that can pass the blood-brain barrier and reduce inflammation in vitro and in vivo[1].


    VX-765 potently and specifically inhibited human Casp1 (IC50 3.68?nM)[2]. Increases of autophagy-related proteins were detected in VX-765-pretreated human umbilical mesenchymal stem cells(HUMSCs), indicating the potential of VX-765 for up-regulating autophagy. Meanwhile, increased p-AMPK and decreased p-mTOR were detected in VX-765-pretreated HUMSCs. Furthermore, the anti-inflammatory and anti-apoptosis effect of VX-765 could be abolished by an autophagy inhibitor or AMPK inhibitor[3]


    In vivo,VX-765 ameliorated renal dysfunction, tubular injury, and renal inflammation in mice with DN, but had no effect on blood glucose level or body weight, illustrating that VX-765 represents a novel and efficacious therapeutic treatment for DN without increasing the risk of hypoglycemia in diabetic patients[4]

    参考文献:
    [1]. Boxer MB, Quinn AM, et al. A highly potent and selective caspase 1 inhibitor that utilizes a key 3-cyanopropanoic acid moiety. ChemMedChem. 2010 May 3;5(5):730-8.
    [2]. Flores J, No?l A, et al. Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer's disease mouse model. Nat Commun. 2018 Sep 25;9(1):3916.
    [3]. Sun Z, Gu L, et al. VX-765 enhances autophagy of human umbilical cord mesenchymal stem cells against stroke-induced apoptosis and inflammatory responses via AMPK/mTOR signaling pathway. CNS Neurosci Ther. 2020 Sep;26(9):952-961.
    [4]. Wen S, Deng F, et al. VX-765 ameliorates renal injury and fibrosis in diabetes by regulating caspase-1-mediated pyroptosis and inflammation. J Diabetes Investig. 2022 Jan;13(1):22-33.


    VX-765 是一种新开发的选择性小分子 caspase-1 抑制剂,可通过血脑屏障并在体外和体内减少炎症[1]


    VX-765 有效且特异性地抑制人 Casp1 (IC50 3.68 nM)[2]。在 VX-765 预处理的人脐带间充质干细胞 (HUMSCs) 中检测到自噬相关蛋白的增加,表明 VX-765 具有上调自噬的潜力。同时,在 VX-765 预处理的 HUMSC 中检测到增加的 p-AMPK 和减少的 p-mTOR。此外,VX-765 的抗炎和抗凋亡作用可被自噬抑制剂或 AMPK 抑制剂消除[3]


    在体内,VX-765 改善了 DN 小鼠的肾功能障碍、肾小管损伤和肾脏炎症,但对血糖水平或体重没有影响,表明 VX-765 代表了一种新型有效的 DN 治疗方法不会增加糖尿病患者发生低血糖的风险[4]

    Protocol

    Cell experiment [1]:

    Cell lines

    human umbilical mesenchymal stem cells(HUMSCs)

    Preparation Method

    MTT assay was used to test the toxicity of VX-765. Oxygen-glucose deprivation (OGD) was applied to mimic ischemic environment in vitro experiments, and The apoptosis of HUMSCs incubated with VX-765 was assessed 12 or 24 hours after OGD exposure.

    Reaction Conditions

    10μM VX-765 for 12, 24h.

    Applications

    Compared to OGD groups, TUNEL-positive cells, IL-1β, and IL-6 decreased while IL-10 increased in VX-765+OGD group. The result demonstrate the anti-apoptosis and anti- inflammatory role of VX-765 in HUMSCs.

    Animal experiment [2]:

    Animal models

    CD1 (ICR) mice

    Preparation Method

    CD1 (ICR) mice were injected intraperitoneally with 55?mg/kg streptozotocin(STZ). Mice with blood glucose level over 300?mg/dL were considered diabetic.Diabetic mice were administered with VX-765 for 8?weeks.The treatment with VX-765 was initiated 2?weeks after STZ injection

    Dosage form

    100mg/kg VX-765, intraperitoneal(i.p.) injection

    Applications

    Administration of VX-765 in diabetic mice effectively ameliorated renal function, compared with that of untreated diabetic mice.VX-765 treatment did not affect blood glucose level or body weight, illustrating that VX-765 ameliorated diabetic nephropathy independent of its metabolic effects.

    参考文献:

    [1]. Sun Z, Gu L, et al. VX-765 enhances autophagy of human umbilical cord mesenchymal stem cells against stroke-induced apoptosis and inflammatory responses via AMPK/mTOR signaling pathway. CNS Neurosci Ther. 2020 Sep;26(9):952-961.


    [2]. Wen S, Deng F, et al. VX-765 ameliorates renal injury and fibrosis in diabetes by regulating caspase-1-mediated pyroptosis and inflammation. J Diabetes Investig. 2022 Jan;13(1):22-33.

    此商品暂时还没有评价哦~

    温馨提示 ×
    商品已成功加入购物车!
    购物车共 0 件商品
    去购物车结算
    回到顶部